欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
MBM-17_2083621-90-1_产品详情
2083621-90-1
  • names:

    MBM-17

  • CAS号:

    2083621-90-1

    MDL Number:
  • MF(分子式): C28H28N6O2 MW(分子量): 480.56
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
MBM-17
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001505-250mg 250mg ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM001505-100mg 100mg >97% ¥ 0.00 ¥ 0.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 2083621-90-1
Inchi
InchiKey
分子式 Formula C28H28N6O2
分子量 Molecular Weight 480.56
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
MBM-17(CAS:2083621-90-1)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 MBM-17 (compound 42c) 为有效的NIMA-related kinase 2 (Nek2)抑制剂,IC50值为 3 nM,通过诱导细胞周期停滞和凋亡,抑制癌细胞的增殖,具有抗肿瘤活性,且对小鼠没有明显的毒性
IntroductionMBM7 (compound 42c) is a potentNIMAelated kinase 2 (Nek2)inhibitor with anIC50of 3 nM. It effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM5 shows antitumor activities, and no obvious toxicity to mice.
Application1
Application2
Application3
MBM-17 (compound 42c) 为有效的NIMA-related kinase 2 (Nek2)抑制剂,IC50值为 3 nM,通过诱导细胞周期停滞和凋亡,抑制癌细胞的增殖,具有抗肿瘤活性,且对小鼠没有明显的毒性。MBM-17 (compound 42c) is a potentNIMA-related kinase 2 (Nek2)inhibitor with anIC50of 3 nM. It effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55 shows antitumor activities, and no obvious toxicity to mice[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Xi JB, et al. Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities. Eur J Med Chem. 2017 Jan 27;126:1083-1106.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents